In the BioHarmony Drug Report Database

"Preview" Icon

Topiramate

Qudexy, Topamax, Topamax Sprinkle, Trokendi (topiramate) is a small molecule pharmaceutical. Topiramate was first approved as Qudexy on 1996-12-24. It is used to treat bipolar disorder, epilepsy, infantile spasms, lennox gastaut syndrome, and pain amongst others in the USA. It is known to target carbonic anhydrase 7, carbonic anhydrase 1, carbonic anhydrase 12, and carbonic anhydrase 4. Topamax’s patents are valid until 2033-03-19 (FDA).

 

Trade Name

 

Qudexy, Topamax, Topamax Sprinkle, Trokendi
 

Common Name

 

topiramate
 

ChEMBL ID

 

CHEMBL220492
 

Indication

 

bipolar disorder, epilepsy, infantile spasms, lennox gastaut syndrome, pain, partial epilepsies, tonic-clonic epilepsy
 

Drug Class

 

Image (chem structure or protein)

Topiramate structure rendering